Abbott Laboratories, Inc recalls The,K -ASSAY HP assay is intended for the quantitative determination of human haptoglobin by immunoturbidimetric assay.…
- Recall date
- May 16, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1993-2019
- FDA classification
- Class II
- Brand / firm
- Abbott Laboratories, Inc
- Sold / distributed
- Distribution was nationwide, including Puerto Rico. There was government/military distribution. Foreign distribution was made to Canada, Albania, Algeria, Andorra, Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovi, Botswana, Brazil, Brun…
Why it was recalled
An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
The,K -ASSAY HP assay is intended for the quantitative determination of human haptoglobin by immunoturbidimetric assay. The antiserum used in the kit was produced against purified human haptoglobin. The haptoglobin antibody interacts with the haptoglobin in the serum forming immune complexes . The immune complexes cause an increase in light scattering which correlates with the concentration of haptoglobin.
Get recall alerts
Free email alert whenever Abbott Laboratories, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Abbott Laboratories, Inc